Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial

T. Sramkova, I. Motil, J. Jarkovsky, K. Sramkova

. 2020 ; 104 (5-6) : 417-424. [pub] 20191211

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, randomizované kontrolované studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc21013007

INTRODUCTION: Low-intensity extracorporeal shock wave therapy (Li-ESWT) is a new treatment modality for erectile dysfunction (ED). Our aim was to evaluate the treatment outcome of Li-ESWT for ED in single-blind, placebo controlled, randomized clinical trial. METHODS: Sixty patients were randomized into 2 age-matched groups: Group A - treatment and Group B - placebo. Treatment consisted of 4 sessions on the PiezoWave2 unit (R. Wolf and ELvation Medical). Effectiveness was assessed according to the International Index of Erectile Function 5 (IIEF-5), Erectile Hardness Score (EHS), questions 2 and 3 of the Sexual Encounter Profile (SEP 2, SEP 3), and Global Assessment Question (GAQ) scores at baseline and 4 and 12 weeks after treatment. We evaluated patient's and partner's subjective satisfaction. RESULTS: A statistically significant difference between the groups was found at 4 and 12 weeks after treatment with regard to the quality of erection as measured by the IIEF-5 (p = 0.049 and p < 0.001, respectively), the EHS after week 12 (p < 0.001), an increase in the EHS after 4 and 12 weeks (p = 0.030 and p < 0.001, respectively), after 12 weeks in GAQ (p < 0.001), SEP 2 (p = 0.05), SEP 3 (p < 0.001), and patient's satisfaction (p < 0.001) and partner's satisfaction (p < 0.001). CONCLUSIONS: The randomized single-blind study confirms that Li-ESWT significantly improves erectile function.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21013007
003      
CZ-PrNML
005      
20210507105019.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.1159/000504788 $2 doi
035    __
$a (PubMed)31825926
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sramkova, Tatjana $u Department of Sexology, University Hospital and Department of Traumatology, Masaryk University, Brno, Czechia, sramkova.t@gmail.com $u Department of Urology First Faculty of Medicine, Charles University Prague and General University Hospital, Prague, Czechia, sramkova.t@gmail.com
245    10
$a Erectile Dysfunction Treatment Using Focused Linear Low-Intensity Extracorporeal Shockwaves: Single-Blind, Sham-Controlled, Randomized Clinical Trial / $c T. Sramkova, I. Motil, J. Jarkovsky, K. Sramkova
520    9_
$a INTRODUCTION: Low-intensity extracorporeal shock wave therapy (Li-ESWT) is a new treatment modality for erectile dysfunction (ED). Our aim was to evaluate the treatment outcome of Li-ESWT for ED in single-blind, placebo controlled, randomized clinical trial. METHODS: Sixty patients were randomized into 2 age-matched groups: Group A - treatment and Group B - placebo. Treatment consisted of 4 sessions on the PiezoWave2 unit (R. Wolf and ELvation Medical). Effectiveness was assessed according to the International Index of Erectile Function 5 (IIEF-5), Erectile Hardness Score (EHS), questions 2 and 3 of the Sexual Encounter Profile (SEP 2, SEP 3), and Global Assessment Question (GAQ) scores at baseline and 4 and 12 weeks after treatment. We evaluated patient's and partner's subjective satisfaction. RESULTS: A statistically significant difference between the groups was found at 4 and 12 weeks after treatment with regard to the quality of erection as measured by the IIEF-5 (p = 0.049 and p < 0.001, respectively), the EHS after week 12 (p < 0.001), an increase in the EHS after 4 and 12 weeks (p = 0.030 and p < 0.001, respectively), after 12 weeks in GAQ (p < 0.001), SEP 2 (p = 0.05), SEP 3 (p < 0.001), and patient's satisfaction (p < 0.001) and partner's satisfaction (p < 0.001). CONCLUSIONS: The randomized single-blind study confirms that Li-ESWT significantly improves erectile function.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a erektilní dysfunkce $x terapie $7 D007172
650    12
$a léčba mimotělní rázovou vlnou $7 D000074059
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a jednoduchá slepá metoda $7 D016037
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Motil, Igor $u EURED Urology, Andrology Center, Brno, Czechia
700    1_
$a Jarkovsky, Jiří $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Sramkova, Katerina $u Department of Urology, St. Anna Hospital, Brno, Czechia
773    0_
$w MED00004616 $t Urologia internationalis $x 1423-0399 $g Roč. 104, č. 5-6 (2020), s. 417-424
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31825926 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507105018 $b ABA008
999    __
$a ok $b bmc $g 1651236 $s 1133386
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 104 $c 5-6 $d 417-424 $e 20191211 $i 1423-0399 $m Urologia internationalis $n Urol Int $x MED00004616
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace